FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

22683211000001107: Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Aug 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
75103601000001116 Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
75103701000001114 Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) Is a Product containing precisely lubiprostone 24 microgram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) Has active ingredient Lubiprostone false Inferred relationship Existential restriction modifier
Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) Is a Amitiza true Inferred relationship Existential restriction modifier
Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) Has specific active ingredient Lubiprostone true Inferred relationship Existential restriction modifier
Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) 56 capsule Has AMP True Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) Inferred relationship Existential restriction modifier
Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) 28 capsule Has AMP True Amitiza 24microgram capsules (Sucampo Pharma Europe Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start